Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.47% |
| 2 | Technology | 8.38% |
| 3 | Healthcare | 7.46% |
| 4 | Consumer Discretionary | 5.14% |
| 5 | Industrials | 5.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MAG
4626
DELISTED
MAG Silver
MAG
| $402K | ﹤0.01% |
36,077
-187,954
| -84% | -$2.34M |
|
|
CIZN
4627
DELISTED
Citizens Holding Co.
CIZN
| $401K | ﹤0.01% |
32,906
-1,963
| -6% | -$24.5K |
|
4628
PUT
Illinois Tool Works
ITW
$80.2B
| $400K | ﹤0.01% |
1,600
-34,200
| -96% | -$8.01M |
|
4629
Phathom Pharmaceuticals
PHAT
$723M
| $400K | ﹤0.01% |
27,941
-29,922
| -52% | -$345K |
|
4630
Glacier Bancorp
GBCI
$6.16B
| $400K | ﹤0.01% |
+12,818
| New | +$423K |
|
4631
CALL
Biomea Fusion
BMEA
$122M
| $399K | ﹤0.01% |
+18,200
| New | +$570K |
|
4632
PUT
United Natural Foods
UNFI
$2.86B
| $399K | ﹤0.01% |
20,400
-5,200
| -20% | -$131K |
|
4633
First Hawaiian
FHB
$3.14B
| $399K | ﹤0.01% |
22,144
-159,904
| -88% | -$2.94M |
|
4634
Atossa Therapeutics
ATOS
$26.3M
| $399K | ﹤0.01% |
21,094
-9,835
| -32% | -$119K |
|
4635
PUT
Capri Holdings
CPRI
$1.5B
| $398K | ﹤0.01% |
+11,100
| New | +$440K |
|
4636
CALL
Sherwin-Williams
SHW
$83.8B
| $398K | ﹤0.01% |
+1,500
| New | +$353K |
|
|
NAAS
4637
NaaS Technology Inc
NAAS
$55.1M
| $398K | ﹤0.01% |
233
+140
| +151% | +$343K |
|
|
TBIO
4638
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
| $398K | ﹤0.01% |
13,982
-5,132
| -27% | -$205K |
|
4639
Eldorado Gold
EGO
$12.5B
| $397K | ﹤0.01% |
39,316
-797,042
| -95% | -$8.44M |
|
4640
Bank of Marin Bancorp
BMRC
$433M
| $397K | ﹤0.01% |
22,471
-107,958
| -83% | -$1.96M |
|
|
ORAN
4641
DELISTED
Orange
ORAN
| $396K | ﹤0.01% |
+34,017
| New | +$413K |
|
|
DEA
4642
Easterly Government Properties
DEA
$1.16B
| $395K | ﹤0.01% |
10,908
-20,434
| -65% | -$718K |
|
4643
Veritone
VERI
$82.4M
| $395K | ﹤0.01% |
100,862
-333,193
| -77% | -$1.45M |
|
4644
Simmons First National
SFNC
$3.28B
| $395K | ﹤0.01% |
22,912
-42,053
| -65% | -$708K |
|
4645
Resources Connection
RGP
$147M
| $393K | ﹤0.01% |
25,017
-54,242
| -68% | -$843K |
|
4646
Nomura Holdings
NMR
$29.6B
| $393K | ﹤0.01% |
102,551
+14,666
| +17% | +$54.3K |
|
4647
First Trust NASDAQ-100 Technology Index Fund
QTEC
$4.83B
| $392K | ﹤0.01% |
2,667
+1,130
| +74% | +$150K |
|
4648
CALL
InMode
INMD
$854M
| $392K | ﹤0.01% |
+10,500
| New | +$367K |
|
|
GRTX
4649
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| $392K | ﹤0.01% |
+125,640
| New | +$374K |
|
4650
CALL
Affirm
AFRM
$26B
| $389K | ﹤0.01% |
25,400
+6,700
| +36% | +$88.9K |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander's Q2 2023 filing shows 870 new, 2,213 increased, 2,337 reduced and 1,192 closed positions. Its largest new stake was ResMed: 632,015 shares worth $138M. The largest sale was Tesla, an estimated $491M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 53% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.